Beam Therapeutics
IPOBreaking new ground to advance science with the potential to change lives
Beam Therapeutics is a biotech company in Cambridge, United States, founded in 2017. It has raised $528.0M across 4 rounds, most recently a $100.0M Growth Equity in February 2026.
- Headquarters
- Cambridge, Massachusetts
- Employees
- 201–500
- Founded
- 2017
- Business Model
- B2B
- Website
- beamtx.com
- Total Funding
- $528.0M
- Last Round
- $100.0M Growth EquityFeb 2026
- Rounds
- 4
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 4 funding rounds and 3 investors for this company. The full record is or through the API.
About
Beam Therapeutics is a clinical-stage biotech company pioneering base editing technology to develop precision genetic medicines. Their platform uses proprietary base editors delivered via nonviral, electroporation, and viral modalities to correct disease-causing mutations in DNA. The company's pipeline targets serious diseases including sickle cell disease, phenylketonuria, and alpha-1 antitrypsin deficiency.
Summary
It lists 201–500 employees. It has raised $528.0M in total across 4 rounds, most recently a $100.0M Growth Equity round in Feb 2026. Investors include F-Prime Capital, ARCH Venture Partners and Sixth Street.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Feb 2026
Sign up to see all 5 events
Funding: Series A through Growth Equity. Amounts, valuations, and investors where available.
Investors
Similar Companies

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/beam-therapeutics"><img src="https://indexed.vc/api/badge/company/beam-therapeutics" alt="Beam Therapeutics on Indexed.vc" width="260" height="76" /></a>
